Nanopharmaceutical Advanced Delivery Systems

1. Nikalje, A.P., Nanotechnology and its applications in medicine. Med. Chem. , 5, 2, 81–89, 2015.

2. Torchilin, V.P., Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS PharmSciTech , 9, 128–147, 2007.

3. Lombardo, D., Kiselev, M.A., Caccamo, M.T., Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine. J. Nanomater. , 2019, Article ID 3702518, 26 pages, 2019. https://doi.org/10.1155/2019/3702518

4. Patra, J.K., Das, G., Fraceto, L.F., Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnol., 16, 71, 2018.

5. Din, F. u., Aman, W., Ullah, I., Qureshi, O.S., Mustapha, O., Shafique, S., Zeb, A., Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int. J. Nanomedicine , 12, 7291–7309, 2017.

6. Wang, E.C. and Wang, A.Z., Nanoparticles and their applications in cell and molecular biology. Integr. Biol. , 6, 1, 9–26, 2014.

7. Boholm, M., The use and meaning of nano in American English: Towards a systematic description. Ampersand , 3, 163–173, 2016.

8. Gunasekaran, T., Haile, T., Nigusse, T., Dhanaraju, M.D., Nanotechnology: An effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pac. J. Trop. Biomed. , 4, 1–7, 2014.

9. Wang, L., The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int. J. Nanomedicine , 12, 1227–1249, 2017.

10. Lohani, A., Verma, A., Joshi, H., Yadav, N., Karki, N., Nanotechnology-based cosmeceuticals. ISRN Dermatol. , 2014, 843687, 2014.

11. Bisht, G. and Rayamajhi, S., ZnO Nanoparticles: A Promising Anticancer Agent. Nanobiomedicine , 3, 9, 2016.

12. Ventola, C.L., Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic? Pharm. Ther. , 36, 10, 669–684, 2011.

13. Vogenberg, F.R., Isaacson Barash, C., Pursel, M., Personalized medicine: part 1: evolution and development into theranostics. Pharm. Ther. , 35, 10, 560–576, 2010.

14. Radhakrishnan, A., Kuppusamy, G., Ponnusankar, S., Shanmukhan, N.K., Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery. Pharmacogenomics J. , 20, 1–18, 2020.

15. Mathur, S. and Sutton, J., Personalized medicine could transform healthcare. Biomed. Rep. , 7, 1, 3–5, 2017.

16. Bengsch, B., Thimme, R., Blum, H.E., IndividualisierteMedizin 2011. Gastroenterologe , 6, 2, 106–111, 2011.

17. Luo, J.-H., Ren, B., Keryanov, S., Tseng, G.C., Rao, U.N.M., Monga, S.P., Strom, S., Demetris, A.J., Nalesnik, M., Yu, Y.P., Ranganathan, S., Michalopoulos, G.K., Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology , 44, 1012–1024, 2006.

18. Spear, B.B., Heath-Chiozzi, M., Huff, J., Clinical application of pharmacogenetics. Trends Mol. Med. , 7, 5, 201–204, 2001.

19. Abrahams, E. and Silver, M., The case for personalized medicine. J. Diabetes Sci. Technol. , 3, 4, 680–684, 2009.

20. Roden, D.M., Wilke, R.A., Kroemer, H.K., Stein, C.M., Pharmacogenomics: the genetics of variable drug responses. Circulation , 123, 15, 1661–1670, 2011.

21. T.P.A., M.S.S., Jose, A., Chandran, L., Zachariah, S.M., Pharmacogenomics: the right drug to the right person. J. Clin. Med. Res. , 1, 4, 191–194, 2009.

22. Warrington, R., Silviu-Dan, F., Wong, T., Drug allergy. Allergy, Asthma Clin. Immunol. , 14, 2, 60, 2018.

23. Arellano, A.L., Martin-Subero, M., Monerris, M., LLerena, A., Farré, M., Montané, E., Multiple adverse drug reactions and genetic polymorphism testing: A case report with negative result. Medicine (Baltimore) , 96, 45, 8505, 2017.

24. Wilke, R.A., Lin, D.W., Roden, D.M., Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat. Rev. Drug Discov. , 6, 11, 904–916, 2007.

25. Gupta, P.D., Pharmacogenetics, pharmacogenomics and ayurgenomics for personalized medicine: a paradigm shift. Indian J. Pharm. Sci. , 77, 2, 135–141, 2015.

26. Pharmacogenetic and Pharmacodynamic Testing, Medical Clinical Policy Bulletins, Aetna , http://www.aetna.com/cpb/medical/data/700_799/0715.html, 2005.

27. Caudle, K.E., Gammal, R.S., Karnes, J.H. et al. , PRN OPINION PAPER: Application of precision medicine across pharmacy specialty areas. J. Am. Coll. Clin. Pharm. , 2, 288–302, 2019. https://doi.org/10.1002/jac5.1107.

28. Gonçalves, G.A.R. and Paiva, R.M.A., Gene therapy: advances, challenges and perspectives. Einstein (Sao Paulo, Brazil) , 15, 3, 369–375, 2017.

29. Riley, M.K. and Vermerris, W., Recent Advances in Nanomaterials for Gene Delivery-A Review. Nanomaterials (Basel) , 7, 5, 94, 2017.

30. Ventola, C.L., Progress in Nanomedicine: Approved and Investigational Nanodrugs. Pharm. Ther. , 42, 12, 742–755, 2017.

31. Farris, E., Brown, D.M., Ramer-Tait, A.E., Pannier, A.K., Micro- and nanoparticulates for DNA vaccine delivery. Exp. Biol. Med. (Maywood) , 241, 9, 919–929, 2016.

32. Khan, I. and Khalid, S., Nanoparticles: Properties, applications and toxicities. Arab. J. Chem. , 12, 7, 908–931, 2019.

33. Mishra, V., Bansal, K.K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., Rosenholm, J.M., Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems. Pharmaceutics , 10, 4, 191, 2018.

34. Ji, S-r., Liu, C., Zhang, B., Yang, F., Xu, J., Long, J., Jin, C., Fu, D.-l., Ni, Q.-x., Yu, X.-j., Carbon nanotubes in cancer diagnosis and therapy. Biochim. Biophys. Acta , 1806, 29–35, 2010.

35. Selvaraj, K., Kuppusamy, G., Krishnamurthy, J., Mahalingam, R., Singh, S.K., Gulati, M., Repositioning of Itraconazole for the Management of Ocular Neovascularization Through Surface-Modified Nanostructured Lipid Carriers. Assay Drug Dev. Technol. , 17, 4, 178–90, 2019.

36. Bhatia, S., Nanopaticles types, classification, characterization, fabrication method and drug delivery applications, Natural polymer drug delivery systems , Springer International Publishing, Switzerland, 2016.

37. Croy, S.R. and Kwon, G.S., Polymeric Micelles for Drug Delivery. Curr. Pharm. Des ., 12, 36, 4669–4684, 2006.

38. Abbasi, E., Aval, S.F., Akbarzadeh, A. et al. , Dendrimers: synthesis, applications, and properties. Nanoscale Res. Lett. , 9, 1, 247, 2014.

39. Venkatesh, N., Metallic Nanoparticle: A Review. Biomed. J. Sci. Tech. Res. , 4, 2, 3765–75, 2018.

40. Kumari, Y., Kaur, G., Kumar, R., Singh, S.K., Gulati, M., Khursheed, R. et al. , Gold nanoparticles: New routes across old boundaries. Adv. Colloid Interface Sci. , 274, 102037, 2019.

41. Mody, V.V., Siwale, R., Singh, A., Mody, H.R., Introduction to metallic nanoparticles. J. Pharm. Bioallied Sci. , 2, 4, 282–289, October-December 2010.

42. Reshma, V.G. and Mohanan, P.V., Quantum dots: Applications and safety consequences. J. Lumin ., 205, 287–298, 2018.

43. Sharma, M., Sharma, R., Jain, D.K., Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water-Soluble Antihypertensive Drugs. Scientifica , 11, 8525679, 2016.

44. Patil, M., Mehta, D.S., Guvva, S., Future impact of nanotechnology on medicine and dentistry. J. Indian Soc. Periodontol. , 12, 2, 34–40, 2008.

45. Raza, S., Blackburn, L., Moorthie, S., Cook, S., Johnson, E., Gaynor, L. et al. , The Personalised Medicine Technology Landscape , p. 206, PHG Foundation, 2018.